• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2010年全球及世界各地区因青光眼致盲或视力受损的人数:一项荟萃分析。

Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis.

作者信息

Bourne Rupert R A, Taylor Hugh R, Flaxman Seth R, Keeffe Jill, Leasher Janet, Naidoo Kovin, Pesudovs Konrad, White Richard A, Wong Tien Y, Resnikoff Serge, Jonas Jost B

机构信息

Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, United Kingdom.

Melbourne School of Population Health, University of Melbourne, Australia.

出版信息

PLoS One. 2016 Oct 20;11(10):e0162229. doi: 10.1371/journal.pone.0162229. eCollection 2016.

DOI:10.1371/journal.pone.0162229
PMID:27764086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5072735/
Abstract

OBJECTIVE

To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012.

METHODS

As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling-Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma.

RESULTS

In 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (<5% in South Asia) than in high-income regions with relatively old populations (>10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women.

SIGNIFICANCE

By 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma.

摘要

目的

评估因青光眼导致视力受损或失明的人数,并研究1990年至2012年期间该参数的地区差异和时间变化。

方法

作为2010年全球疾病负担(GBD)研究的一部分,我们对1980年至2012年期间的文献进行了系统回顾。我们初步识别出14908篇相关手稿,经过一个专家小组审查后,根据人口代表性和所使用视力测定方法的清晰度等选择标准,最终保留了243项高质量的基于人群的研究。其中66项明确了青光眼所致比例。利用GBD的软件工具DisMod-MR(疾病建模-元回归)计算青光眼所致视力损害的比例。

结果

2010年,210万人(95%不确定区间(UI):190万,260万)因青光眼失明,420万人(95%UI:370万,580万)因青光眼视力受损。2010年,青光眼导致全球所有失明病例的6.6%(95%UI:5.9%,7.9%)以及所有中度和重度视力损害(MSVI)病例的2.2%(95%UI:2.0%,2.8%)。在人口较年轻的地区(南亚<5%),这些数字低于人口相对老龄化的高收入地区(>10%)。1990年至2010年,因青光眼失明或视力受损的人数分别增加了80万(95%UI:70万,110万)或62%,以及230万(95%UI:210万,350万)或83%。1990年至2010年,青光眼导致的全球失明比例从4.4%(4.0%,5.1%)增至6.6%。世界各地区以及女性之间,青光眼相关失明和MSVI的年龄标准化患病率无明显差异。

意义

到2010年,每15名盲人中有1人因青光眼失明,每45名视力受损者中有1人因青光眼视力受损,凸显青光眼的全球负担日益加重。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503b/5072735/82f88b198508/pone.0162229.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503b/5072735/82f88b198508/pone.0162229.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503b/5072735/82f88b198508/pone.0162229.g001.jpg

相似文献

1
Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis.1990 - 2010年全球及世界各地区因青光眼致盲或视力受损的人数:一项荟萃分析。
PLoS One. 2016 Oct 20;11(10):e0162229. doi: 10.1371/journal.pone.0162229. eCollection 2016.
2
Visual impairment and blindness due to macular diseases globally: a systematic review and meta-analysis.全球因黄斑疾病导致的视力损害和失明:一项系统评价与荟萃分析。
Am J Ophthalmol. 2014 Oct;158(4):808-15. doi: 10.1016/j.ajo.2014.06.012. Epub 2014 Jun 25.
3
Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020.全球因青光眼致盲或视力受损人数的估计:2000 年至 2020 年的荟萃分析。
Eye (Lond). 2024 Aug;38(11):2036-2046. doi: 10.1038/s41433-024-02995-5. Epub 2024 Apr 2.
4
Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010.1990年至2010年全球及世界各地区因白内障致盲或视力受损的人数。
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6762-9. doi: 10.1167/iovs.15-17201.
5
Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010.全球因糖尿病视网膜病变致盲或视力受损人数的估计:1990 年至 2010 年的荟萃分析。
Diabetes Care. 2016 Sep;39(9):1643-9. doi: 10.2337/dc15-2171.
6
Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010.全球视力障碍和失明的患病率:1990-2010 年的规模和时间趋势。
Ophthalmology. 2013 Dec;120(12):2377-2384. doi: 10.1016/j.ophtha.2013.05.025. Epub 2013 Jul 10.
7
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.2020 年失明和视力障碍的原因及 30 多年来的趋势,以及与 VISION 2020:看见的权利相关的可避免盲的患病率:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
8
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.30 多年来盲症和远距离及近距离视力损伤流行率的变化趋势:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e130-e143. doi: 10.1016/S2214-109X(20)30425-3. Epub 2020 Dec 1.
9
Global Vision Impairment and Blindness Due to Uncorrected Refractive Error, 1990-2010.1990 - 2010年因未矫正屈光不正导致的全球视力损害和失明情况
Optom Vis Sci. 2016 Mar;93(3):227-34. doi: 10.1097/OPX.0000000000000796.
10
Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia.南亚和中亚的盲症和视力损害的流行率及其原因:规模、时间趋势和预测。
Br J Ophthalmol. 2019 Jul;103(7):871-877. doi: 10.1136/bjophthalmol-2018-312292. Epub 2018 Nov 8.

引用本文的文献

1
Micropulse Cyclophotocoagulation versus Ultrasound Cycloplasty in a Tertiary Eye Care Center in Riyadh, Saudi Arabia.沙特阿拉伯利雅得一家三级眼科护理中心的微脉冲睫状体光凝术与超声睫状体成形术对比研究
Clin Ophthalmol. 2025 Jul 17;19:2373-2381. doi: 10.2147/OPTH.S519777. eCollection 2025.
2
[Open-angle glaucoma: Who is affected and what are the risk factors?].[开角型青光眼:哪些人会患病以及风险因素有哪些?]
Ophthalmologie. 2025 Jun 4. doi: 10.1007/s00347-025-02255-1.
3
Beacon of Hope for Age-Related Retinopathy: Antioxidative Mechanisms and Pre-Clinical Trials of Quercetin Therapy.

本文引用的文献

1
Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010.全球因糖尿病视网膜病变致盲或视力受损人数的估计:1990 年至 2010 年的荟萃分析。
Diabetes Care. 2016 Sep;39(9):1643-9. doi: 10.2337/dc15-2171.
2
Global Vision Impairment and Blindness Due to Uncorrected Refractive Error, 1990-2010.1990 - 2010年因未矫正屈光不正导致的全球视力损害和失明情况
Optom Vis Sci. 2016 Mar;93(3):227-34. doi: 10.1097/OPX.0000000000000796.
3
Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010.
年龄相关性视网膜病变的希望之光:槲皮素治疗的抗氧化机制及临床前试验
Antioxidants (Basel). 2025 May 8;14(5):561. doi: 10.3390/antiox14050561.
4
Effects of Verteporfin on Interstitial Fluid Flow-Induced Fibrotic Transdifferentiation of Human Tenon Fibroblasts.维替泊芬对人Tenon成纤维细胞间质液流动诱导的纤维化转分化的影响
Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):17. doi: 10.1167/iovs.66.4.17.
5
Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions.Rho激酶抑制剂在青光眼治疗中的应用:当前观点与未来方向
Drug Des Devel Ther. 2025 Apr 2;19:2519-2531. doi: 10.2147/DDDT.S515166. eCollection 2025.
6
Common tandem repeat variants associated with glaucoma risk in individuals of African ancestry.与非洲裔个体青光眼风险相关的常见串联重复变异体。
medRxiv. 2025 Feb 21:2025.02.19.25322489. doi: 10.1101/2025.02.19.25322489.
7
Ab-Externo XEN Gel stent implantation effectively treated refractory glaucoma with prior failed shunt tube.经皮外路可降解 XEN 凝胶支架植入术有效治疗了既往分流管失败的难治性青光眼。
BMC Ophthalmol. 2024 Aug 30;24(1):384. doi: 10.1186/s12886-024-03648-7.
8
Generation of an Armcx1 Conditional Knockout Mouse.生成 Armcx1 条件性敲除小鼠。
Genesis. 2024 Aug;62(4):e23615. doi: 10.1002/dvg.23615.
9
Impact of COVID-19 on glaucoma management: A review.2019冠状病毒病对青光眼治疗的影响:综述
Front Ophthalmol (Lausanne). 2022 Sep 28;2:1003653. doi: 10.3389/fopht.2022.1003653. eCollection 2022.
10
Corneal thickness and endothelial change after use of ocular hypotensive agents.使用降眼压药物后的角膜厚度和内皮变化。
Kaohsiung J Med Sci. 2024 Jul;40(7):671-677. doi: 10.1002/kjm2.12840. Epub 2024 May 28.
1990年至2010年全球及世界各地区因白内障致盲或视力受损的人数。
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6762-9. doi: 10.1167/iovs.15-17201.
4
Causes of vision loss worldwide, 1990-2010: a systematic analysis.全球视力丧失的原因,1990-2010 年:一项系统分析。
Lancet Glob Health. 2013 Dec;1(6):e339-49. doi: 10.1016/S2214-109X(13)70113-X. Epub 2013 Nov 11.
5
Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.全球青光眼患病率及 2040 年青光眼负担预测:系统评价和荟萃分析。
Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 2014 Jun 26.
6
Visual impairment and blindness due to macular diseases globally: a systematic review and meta-analysis.全球因黄斑疾病导致的视力损害和失明:一项系统评价与荟萃分析。
Am J Ophthalmol. 2014 Oct;158(4):808-15. doi: 10.1016/j.ajo.2014.06.012. Epub 2014 Jun 25.
7
Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010.高收入国家以及东欧和中欧地区视力丧失的患病率及原因:1990 - 2010年
Br J Ophthalmol. 2014 May;98(5):629-38. doi: 10.1136/bjophthalmol-2013-304033. Epub 2014 Mar 24.
8
Prevalence and causes of vision loss in North Africa and the Middle East: 1990-2010.1990 - 2010年北非和中东地区视力丧失的患病率及原因
Br J Ophthalmol. 2014 May;98(5):605-11. doi: 10.1136/bjophthalmol-2013-304068. Epub 2014 Mar 3.
9
Prevalence and causes of vision loss in sub-Saharan Africa: 1990-2010.1990 - 2010年撒哈拉以南非洲地区视力丧失的患病率及原因
Br J Ophthalmol. 2014 May;98(5):612-8. doi: 10.1136/bjophthalmol-2013-304081. Epub 2014 Feb 25.
10
Prevalence and causes of vision loss in Latin America and the Caribbean: 1990-2010.1990 - 2010年拉丁美洲和加勒比地区视力丧失的患病率及原因
Br J Ophthalmol. 2014 May;98(5):619-28. doi: 10.1136/bjophthalmol-2013-304013. Epub 2014 Feb 11.